Medelis is a full service oncology CRO. We provide sponsors with a highly-skilled and proactive oncology clinical trial management team to design and manage phase I and II oncology clinical trials in North America and Europe.
We provide a proactive approach to streamline the planning and management of complex oncology clinical trials, and value building relationships with our partners. That’s the value in working with a small, specialized CRO.
Oncology trials are complex. We specialize in oncology, and our entire team has deep oncology trial experience and expertise — from our world-class medical advisory board to our clinical team members and medical personnel. This critical first-hand experience in the complex issues often associated with oncology clinical trials means that highly experienced resources will be working on your study.
We’ve handled most targets within oncology. Whether it’s a standard dose-escalation phase I trial or a complex rescue of a phase III trial, chances are that our team has handled it before.
We’re a single-source oncology contract research organization for clinical trial planning, trial management and drug development planning, providing the following services for sponsors running clinical studies in North America and Europe:
Our clinical team’s comprehension of the complex issues of oncology trials translates into better problem identification, decision making and superior results. We value innovation, and our experience allows us to work smarter, to maximize cost and time efficiencies on your trial.
We’re flexible, collaborative and proactive, and able to quickly adapt to study challenges or changes in the regulatory or competitive environment. This helps to speed a drug to market, and provides the decision support to determine your next clinical move.
Contact us to learn more about how we’re helping sponsors bring oncology drugs to market.
We’d love to hear from you, and can provide feedback about your study design, investigators and patient recruitment, indications, and data collection.